Your browser doesn't support javascript.
loading
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
Chung, Stephen S; Kim, Eunhee; Park, Jae H; Chung, Young Rock; Lito, Piro; Teruya-Feldstein, Julie; Hu, Wenhuo; Beguelin, Wendy; Monette, Sebastien; Duy, Cihangir; Rampal, Raajit; Telis, Leon; Patel, Minal; Kim, Min Kyung; Huberman, Kety; Bouvier, Nancy; Berger, Michael F; Melnick, Ari M; Rosen, Neal; Tallman, Martin S; Park, Christopher Y; Abdel-Wahab, Omar.
Afiliação
  • Chung SS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kim E; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Park JH; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Chung YR; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Lito P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Teruya-Feldstein J; Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hu W; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Beguelin W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Monette S; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
  • Duy C; Tri-Institutional Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, Rockefeller University, New York, NY 10065, USA.
  • Rampal R; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
  • Telis L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Patel M; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kim MK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Huberman K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Bouvier N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Berger MF; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Melnick AM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Rosen N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Tallman MS; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Park CY; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Abdel-Wahab O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sci Transl Med ; 6(238): 238ra71, 2014 May 28.
Article em En | MEDLINE | ID: mdl-24871132

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Leucemia de Células Pilosas / Proteínas Proto-Oncogênicas B-raf / Mutação Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Leucemia de Células Pilosas / Proteínas Proto-Oncogênicas B-raf / Mutação Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article